4881

FunPep Company Limited

ファンペップ

Industry
Pharmaceutical
Market
Growth
Accounting standards
Japanese GAAP
Consolidation basis
Consolidated

Notes

  • Consolidation basis
    Consolidated / Since Dec 2022

Key metrics

Revenue(thousand JPY)

Dec 2021
126,869
Dec 2022
1,067
Dec 2023
530
Dec 2024
6,127
Dec 2025
314

Operating profit(thousand JPY)

Dec 2021
-745,044
Dec 2022
-1,169,069
Dec 2023
-994,108
Dec 2024
-901,758
Dec 2025
-1,648,668

Operating profit margin(%)

Dec 2021
-587.25
Dec 2022
-109,565.98
Dec 2023
-187,567.55
Dec 2024
-14,717.77
Dec 2025
-525,053.5

Profit before tax(thousand JPY)

Dec 2021
-679,654
Dec 2022
-1,175,229
Dec 2023
-940,420
Dec 2024
-896,128
Dec 2025
-2,011,192

Profit(thousand JPY)

Dec 2021
-682,265
Dec 2022
-1,172,515
Dec 2023
-933,416
Dec 2024
-889,092
Dec 2025
-1,911,527

Total assets(thousand JPY)

Dec 2021
3,364,713
Dec 2022
2,992,694
Dec 2023
2,491,134
Dec 2024
3,110,655
Dec 2025
1,980,860

Cash and cash equivalents(thousand JPY)

Dec 2021
3,007,138
Dec 2022
2,245,438
Dec 2023
1,793,378
Dec 2024
2,346,111
Dec 2025
1,768,476

Cash flows from operating activities(thousand JPY)

Dec 2021
-887,466
Dec 2022
-1,053,151
Dec 2023
-988,815
Dec 2024
-536,735
Dec 2025
-1,387,571

Cash flows from investing activities(thousand JPY)

Dec 2021
-4,753
Dec 2022
-19,141
Dec 2023
-1,055
Dec 2024
-30,834
Dec 2025
-993

Cash flows from financing activities(thousand JPY)

Dec 2021
282,680
Dec 2022
245,125
Dec 2023
537,810
Dec 2024
1,120,303
Dec 2025
810,930

Return on equity(-)

Dec 2021
-
Dec 2022
-
Dec 2023
-
Dec 2024
-
Dec 2025
-

Equity ratio(%)

Dec 2021
94.28
Dec 2022
89.95
Dec 2023
92.4
Dec 2024
81.6
Dec 2025
72.74

Earnings per share(JPY per share)

Dec 2021
-39.58
Dec 2022
-61.04
Dec 2023
-39.63
Dec 2024
-31.98
Dec 2025
-50.2

Net assets per share(JPY per share)

Dec 2021
178.57
Dec 2022
125.79
Dec 2023
94.97
Dec 2024
78.31
Dec 2025
35.52

Dividend per share(-)

Dec 2021
-
Dec 2022
-
Dec 2023
-
Dec 2024
-
Dec 2025
-

Payout ratio(-)

Dec 2021
-
Dec 2022
-
Dec 2023
-
Dec 2024
-
Dec 2025
-

Disclaimer

The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.

The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.